1. Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma
    Min Kyu Kang et al, 2018, Medicine CrossRef
  2. Efficacy and optimal treatment sequence of Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
    Yasunari Hiramine et al, 2013, Kanzo CrossRef
  3. New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
    Hyun Young Woo et al, 2015, Clinical and Molecular Hepatology CrossRef
  4. Pseudo-capsulated Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization
    Chao An et al, 2024, Academic Radiology CrossRef
  5. Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Bo-wen Zhuang et al, 2019, Japanese Journal of Clinical Oncology CrossRef
  6. Current management of hepatocellular carcinoma: An Eastern perspective
    Hyung Joon Yim, 2015, World Journal of Gastroenterology CrossRef
  7. Expression of human leukocyte antigen-G and acute rejection in patients following liver transplantation
    WEI-YU HU et al, 2014, Experimental and Therapeutic Medicine CrossRef
  8. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity scoreā€based weighting
    Masaaki Kondo et al, 2015, Journal of Digestive Diseases CrossRef
  9. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
    Reina Sasaki et al, 2019, International Journal of Molecular Sciences CrossRef
  10. Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index
    Takamasa Ohki et al, 2017, Advances in Therapy CrossRef
  11. The Role of Hepatic Arterial Infusion Chemotherapy in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Shengzhou Li et al, 2021, Chemotherapy CrossRef
  12. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Jong Hwan Choi et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef
  13. Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method
    Kotaro Fukubayashi et al, 2015, Cancer Medicine CrossRef
  14. Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series
    TOMOYUKI NEMOTO et al, 2014, Molecular and Clinical Oncology CrossRef
  15. A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Do Seon Song et al, 2015, Journal of Gastroenterology CrossRef
  16. Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin
    Sun Hong Yoo et al, 2020, Cancer Control CrossRef